MIRA INFORM REPORT

 

 

Report Date :

06.01.2014

 

IDENTIFICATION DETAILS

 

Name :

ERIS LIFESCIENCES PRIVATE LIMITED (w.e.f. 09.02.2007)

 

 

Formerly Known As :

ERIS LIFESCIENCE PRIVATE LIMITED

 

 

Registered Office :

21, New York Tower - A, Near Muktidham Temple, Thaltej Cross Road, Thaltej , Ahmedabad – 380 054, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

25.01.2007

 

 

Com. Reg. No.:

04-049867

 

 

Capital Investment / Paid-up Capital :

Rs.1.375 millions

 

 

CIN No.:

[Company Identification No.]

U24232GJ2007PTC049867

 

 

PAN No.:

[Permanent Account No.]

AABCE7067M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2748000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Overall financial position of the company appears to be strong.

 

Trade relations are reported to be fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

Note:

Latest financials of 2013 is not available with us.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit narrowed in the quarter ended September as government measures to curb imports, especially gold, kicked in.  The current account deficit, the excess of a country’s imports of goods and services over exports, narrowed to $ 5.2 billion from $ 21 billion in the year ago period, according to provisional Reserve Bank of India data. Finance Minister P. Chidambaram said the CAD for the year will be less than $ 60 billion or 3 per cent of GDP and the latest data suggests the government may achieve the target.

 

India was ranked 94th among the world’s most corrupt nations list. Denmark and New Zealand topped as the cleanest while Somalia emerged as the most corrupt.

 

India’s services sector activity witnessed a moderate improvement in November over the previous month, even while indicating the fifth successive monthly contraction, according the HSBC survey.

 

$53 million estimated losses suffered by India due to phishing attacks during the third quarter, according to a study by RSA. India ranks fourth in the list of nations hit by phishing attacks. The US remained at the top of the charts. Phishing is the process of acquiring information such as user names, passwords and credit card details by sending e-mails disguised as official mails.

 

Rs.4080 million worth of mobile-phone-based transactions by July 2013 compared to Rs.260 million in September, 2012, according to Deloitte report. The number of transactions has shot up from 94000 to 701000.

 

India aims to earn Rs.400000 million from the bandwidth auction set for January. The merger and acquisition guidelines, cleared by a group of ministers, will be out before the auction begins so that players can make informed decisions on the auctions.

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Ms. Kinnari

Designation :

Accounts Executive

Contact No.:

91-79-30451111

Date :

06.01.2014

 

 

LOCATIONS

 

Registered Office :

21, New York Tower - A, Near Muktidham Temple, Thaltej Cross Road, Thaltej , Ahmedabad – 380 054, Gujarat, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

info@eris.co.in

ho.admin@erislifesciences.com

Website :

http://www.eris.co.in

Location :

Owned

 

 

Corporate Office :

7th Floor, Commerce House IV, Besides Shell Petrol Pump, 100 Feet Road Prahladnagar, Ahmedabad – 380 015, Gujarat, India

Tel. No.:

91-79-30451111

Fax No.:

91-79-30451001

 

 

DIRECTORS

 

AS ON 11.09.2013

 

Name :

Mr. Amit Indubhushan Bakshi

Designation :

Managing Director

Address :

01, Amrakadam Co-Operative Housing Society, Opposite Shukan Flats, Ramdevnagar Satellite, Ahmedabad – 380 015, Gujarat, India

Date of Birth/Age :

28.11.1974

Date of Appointment :

27.01.2007

DIN No.:

01250925

PAN No.:

AGIPB4441Q

 

 

Name :

Mr. Himanshu Jayantbhai Shah

Designation :

Director

Address :

A/74, Yash Tower, Near Shwetanjali Society, Opposite, Hasubhai Park, Jodhpur Gam, Ahmedabad – 380 018, Gujarat, India

Date of Birth/Age :

09.04.1976

Date of Appointment :

27.01.2007

DIN No.:

01301025

 

 

Name :

Mr. Rajendra Rambhai Patel

Designation :

Director

Address :

H-103, Akash - 3, 132ft Ring Road, Naranpura, Ahmedabad – 380 013, Gujarat, India

Date of Birth/Age :

16.02.1977

Date of Appointment :

16.08.2012

DIN No.:

01229080

 

 

Name :

Mr. Inderjeet Singh Negi

Designation :

Director

Address :

B-22C, Rajat Vihar, Sector-62, Noida – 201 301, Uttar Pradesh, India

Date of Birth/Age :

22.06.1971

Date of Appointment :

25.01.2007

DIN No.:

01255388

 

 

Name :

Mr. Kaushal Kamlesh Shah

Designation :

Director

Address :

2-B, Paradise Park, Opposite Shantinagar Bus Stop, Jain Agan Mandir, Ashram Road, Ahmedabad – 380 014, Gujarat, India

Date of Birth/Age :

12.07.1979

Date of Appointment :

27.01.2007

DIN No.:

01229038

 

 

Name :

Mr. Bhikhabhai Chimanlal Shah

Designation :

Director

Address :

Paras '7', Vidhyanagar Society, No.III, Usmanpura, Ahmedabad – 380 013, Gujarat, India

Date of Birth/Age :

24.05.1939

Date of Appointment :

25.01.2007

DIN No.:

01217618

 

 

Name :

Mr. Sanjiv Dwarkanath Kaul

Designation :

Director

Address :

22, Siris Road, DLF Qutab Enclave, Phase - 3, Gurgaon – 122 002, Haryana, India

Date of Birth/Age :

25.07.1957

Date of Appointment :

29.08.2011

DIN No.:

01550413

 

 

KEY EXECUTIVES

 

Name :

Ms. Kinnari

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 11.09.2013

 

Names of Shareholders

 

 

No. of Shares

Amit Indubhushan Bakshi

 

51521

Himanshu Jayantbhai Shah

 

6972

Rajendra Rambhai Patel

 

6971

Inderjeet Singh Negi

 

6971

Kaushal Kamlesh Shah

 

5500

Hetal Rasiklal Shah

 

5500

Rakesh Bhikhalal Shah

 

15867

Bhikhabhai Chimanlal Shah

 

15854

Botticelli, India

 

22344

Total

 

137500

 

AS ON 11.09.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

16.25

Directors or relatives of directors

 

83.75

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

Products :

·         Pharmaceutical Tablets

·         Pharmaceutical Injections

·         Pharmaceutical Syrup

 

 

Terms :

 

Selling :

L/C and Credit

 

 

Purchasing :

L/C and Credit

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

Bank of Baroda, Navrangpura Branch, Navrangpura, Ahmedabad – 380 009, Gujarat, India (Tel. No.: 91-79-27541494) 

 

 

Facilities :

Secured Loans

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Other loans and advances

(Secured against Car)

3.810

10.531

Total

3.810

10.531

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

R.R.S. and Associates

Chartered Accountants

Address :

211, Kamal Complex, C.G. Road, Navrangpura, Ahmedabad – 380 009, Gujarat, India

PAN No.:

AAFFR0472A

 

 

Subsidiary Companies :

Eris Therapeutics Private Limited, India (CIN No.: U24230GJ2009PTC057670)

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

Sozin Flora Pharma, India

 

 

CAPITAL STRUCTURE

 

AS ON 11.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs.10/- each

Rs.100.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

137500

Equity Shares

Rs.10/- each

Rs.1.375 millions

 

 

 

 

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

2000000

Equity Shares

Rs.10/- each

Rs.20.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

137500

Equity Shares

Rs.10/- each

Rs.1.375 millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

 

1.375

1.375

(b) Reserves & Surplus

 

685.558

194.251

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

686.933

195.626

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

 

25.809

37.078

(b) Deferred tax liabilities (Net)

 

1.804

2.624

(c) Other long term liabilities

 

0.000

0.000

(d) Long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

27.613

39.702

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

115.591

138.295

(c) Other current liabilities

 

41.125

34.980

(d) Short-term provisions

 

323.080

196.827

Total Current Liabilities (4)

 

479.796

370.102

 

 

 

 

TOTAL

 

1194.342

605.430

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

105.865

65.049

(ii) Intangible Assets

 

0.487

0.209

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

56.679

27.149

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

14.827

11.094

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

177.858

103.501

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

134.516

51.781

(b) Inventories

 

239.612

162.229

(c) Trade receivables

 

141.839

73.299

(d) Cash and cash equivalents

 

81.157

3.855

(e) Short-term loans and advances

 

419.360

210.765

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

1016.484

501.929

 

 

 

 

TOTAL

 

1194.342

605.430

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

1.100

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

47.378

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

48.478

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

14.485

2] Unsecured Loans

 

 

36.172

TOTAL BORROWING

 

 

50.657

DEFERRED TAX LIABILITIES

 

 

2.674

 

 

 

 

TOTAL

 

 

101.809

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

41.715

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.038

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

66.992

 

Sundry Debtors

 

 

60.160

 

Cash & Bank Balances

 

 

(59.241)

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

52.105

Total Current Assets

 

 

120.016

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

12.653

 

Other Current Liabilities

 

 

2.824

 

Provisions

 

 

44.667

Total Current Liabilities

 

 

60.144

Net Current Assets

 

 

59.872

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.184

 

 

 

 

TOTAL

 

 

101.809

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

 

31.03.2012

31.03.2011

 

GROSS REVENUE FROM OPERATIONS

 

3055.896

1652.394

 

 

 

 

 

 

OPERATING PROFIT BEFORE TAX AND EXCEPTIONAL ITEM

 

662.587

305.067

 

 

 

 

 

 

NET PROFIT AFTER EXCEPTIONAL ITEMS, PRIOR YEAR ADJUSTMENTS AND PROVISION FOR TAXES

 

491.307

203.117

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

3573.14

1477.21

 

 

 

PARTICULARS

 

 

 

31.03.2010

 

SALES

 

 

 

 

Income

 

 

955.494

 

 

Other Income

 

 

 

 

 

TOTAL                                    

 

 

955.494

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

866.008

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                        

 

 

866.008

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

 

89.486

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

 

7.557

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

 

 

81.929

 

 

 

 

 

Less

TAX                                                                 

 

 

28.682

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

 

 

53.247

 

 

 

 

 

Less

Proposed Dividend (Inclusive of Tax)

 

 

6.435

 

 

 

 

 

 

Net Balance Carried Forward

 

 

46.813

 

 

 

 

 

Add

Balance Brought Forward

 

 

0.565

 

 

 

 

 

 

Reserve and Surplus

 

 

47.378

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

 

484.07

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

NA
NA

5.57

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
NA

50.66

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA
NA

1.69

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.04

0.19

1.04

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.12

1.36

1.99

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Current maturities of long-term debt:

 

Particulars

 

31.03.2012

(Rs. in millions)

31.03.2011

(Rs. in millions)

31.03.2010

(Rs. in millions)

Current maturities of long-term debt

8.579

9.849

NA

 

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

Yes

10) Designation of contact person

Yes

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

Yes

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

No

30) Major Shareholders, if available

Yes

31) Date of Birth of Proprietor/Partner/Director, if available

Yes

32) PAN of Proprietor/Partner/Director, if available

Yes

33) Voter ID No of Proprietor/Partner/Director, if available

No

34) External Agency Rating, if available

No

 


Note:

The registered office of the company has been shifted from A/F-10, Kanchan Pharma House, Aslali, Ahmedabad – 382 427, Gujarat to the present address w.e.f. 08.05.2012.

 

Unsecured Loans

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Inter Corporate Borrowings

0.000

4.966

Deposits from others (Trade Deposit)

21.999

21.581

Total

21.999

26.547

 

 

Note:

No Charges Exist for Company.

 

FIXED ASSETS:

Tangible assets

·         Land

·         Buildings

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipments

·         Books Periodicals

Intangible assets

·         Brands and Trade Marks

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.41

UK Pound

1

Rs.102.54

Euro

1

Rs.85.20

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

SMN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

5

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.